- Investing Ideas
- U.S. Pharmaceuticals & Biotech Nano Cap Stocks
U.S. Pharmaceuticals & Biotech Nano Cap Stocks
Results
18
Stocks with a market cap under US$50M.
18 companies
Mereo BioPharma Group
Market Cap: US$49.1m
A biopharmaceutical company, develops and commercializes therapeutics for the treatment of rare diseases in the United Kingdom and the United States.
MREO
US$0.32
7D
7.6%
1Y
-81.7%
Grace Therapeutics
Market Cap: US$43.5m
Engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada.
GRCE
US$2.16
7D
1.4%
1Y
-33.7%
BioXcel Therapeutics
Market Cap: US$34.9m
Together with its subsidiary, OnkosXcel Therapeutics LLC, operates as a biopharmaceutical company that utilizes artificial intelligence approaches to develop medicines in neuroscience and immuno-oncology in the United States.
BTAI
US$1.19
7D
32.0%
1Y
-78.3%
Bioqual
Market Cap: US$29.1m
Provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States.
BIOQ
US$32.50
7D
0%
1Y
n/a
Dyadic International
Market Cap: US$28.1m
A biotechnology platform company, develops, manufactures, and commercializes proteins and enzymes in the United States.
DYAI
US$0.78
7D
-22.5%
1Y
3.6%
Earth Science Tech
Market Cap: US$26.5m
Together with its subsidies, focuses on health and wellness industry.
ETST
US$0.09
7D
-8.1%
1Y
-56.1%
Jasper Therapeutics
Market Cap: US$24.2m
A clinical-stage biotechnology company, focuses on developing therapeutics targeting mast stem cell driven diseases in the United States.
JSPR
US$0.79
7D
11.4%
1Y
-74.6%
TherapeuticsMD
Market Cap: US$24.1m
Operates as a pharmaceutical royalty company in the United States and internationally.
TXMD
US$2.07
7D
0%
1Y
76.9%
MDxHealth
Market Cap: US$23.7m
A commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally.
MDXH
US$0.81
7D
75.3%
1Y
-71.6%
Cellectar Biosciences
Market Cap: US$19.8m
A clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer in the United States.
CLRB
US$2.60
7D
1.2%
1Y
-40.1%
Biofrontera
Market Cap: US$16.1m
A biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.
BFRI
US$1.30
7D
2.4%
1Y
39.8%
Bio Essence
Market Cap: US$13.5m
Engages in manufacturing and distributing health supplement products.
BIOE
US$0.25
7D
0%
1Y
163.2%
PDS Biotechnology
Market Cap: US$13.0m
A clinical-stage biopharmaceutical company, developing a pipeline of targeted cancer immunotherapies in the United States.
PDSB
US$0.23
7D
-70.3%
1Y
-80.6%
Pharma-Bio Serv
Market Cap: US$12.4m
Operates as a regulatory affair, compliance, and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally.
PBSV
US$0.54
7D
-6.9%
1Y
-10.0%
Traws Pharma
Market Cap: US$9.1m
A clinical-stage biopharmaceutical company, develops small synthetic molecules for respiratory viral diseases and cancer.
TRAW
US$0.57
7D
7.3%
1Y
-62.2%
CordovaCann
Market Cap: US$4.4m
Engages in the provision of services and investment capital to the processing, production, and retail vertical markets of the cannabis industry in Canada and United States.
LVRL.F
US$0.04
7D
0%
1Y
-33.0%
Ayurcann Holdings
Market Cap: US$58.4k
Provides post-harvest outsourcing solutions to licensed cannabis producers in Canada.
AYUR.F
US$0.0003
7D
0%
1Y
-98.3%
Sunset Island Group
Market Cap: US$34.4k
Through its subsidiary, VBF Brands, grows, cultivates, manufactures, and distributes cannabis in the United States.
SIGO
US$0.0001
7D
0%
1Y
0%